BETA
Diversified medical technology manufacturer with businesses spanning orthopaedics, surgical instruments and visualization, acute and emergency care, neurovascular intervention and peripheral vascular devices.
Stryker Corporation is a publicly traded medical technology company headquartered in Portage, Michigan. Founded in 1941 by orthopaedic surgeon Homer Stryker, it develops and markets devices, equipment and related technologies across multiple clinical and care settings.
The company reports approximately $25.1 billion in global sales and 56,000 employees for 2025. Its business directory extends beyond joint replacement to surgical equipment, hospital and emergency care, neurovascular and peripheral vascular devices, and other specialized businesses.
The portfolio has changed through acquisitions and divestitures. Stryker completed its acquisition of Inari Medical in February 2025 and sold its U.S. spinal implants business to the newly formed VB Spine in April 2025. Retained navigation and enabling technologies are distinguished from divested implants in this profile.
Covers Stryker Corporation and selected manufacturer-branded businesses, including Inari-origin vascular products, as of October 27, 2026. The U.S. spinal implants business sold to VB Spine is excluded. Product snapshots emphasize U.S. documentation and do not establish worldwide availability.
Hip and knee replacement, trauma fixation, foot and ankle, and sports medicine products. The selected examples distinguish robotic assistance, knee implants, hip cups and tibial fracture fixation. [67][77][75][76][83]
Powered surgical instruments and endoscopic imaging systems. System 9 and the 1788 platform illustrate reusable equipment and visualization without listing their individual components. [80][74]
Hospital beds, patient handling and emergency response equipment. ProCuity LEX/ZX and LIFEPAK 35 represent distinct hospital and prehospital workflows. [72][73]
Products for ischemic stroke and aneurysm treatment. Trevo NXT retrieves clot; Surpass Evolve is an implanted flow-diversion system with a different clinical purpose. [79][78]
The selected FDA evidence includes nine 510(k) decisions associated with the displayed families. One of those decisions, K242834, covers the System 9 Sterile Battery Container only. It does not establish clearance of every tool or accessory in that platform. [4][5][6][7][11][12][10][8][9]
Surpass Evolve is documented through PMA supplement P170024/S003, and LIFEPAK 35 through P160026/S040 under Physio-Control. These are product-specific supplement approvals, not two new original PMAs; they are excluded from the original-PMA count. Other FDA records retain applicants such as Howmedica, Mako Surgical and Inari Medical. [3][2][6][4][8]
FDA records report open recall events involving specified Mako components/software, Triathlon components or instruments, ProCuity beds, LIFEPAK products/accessories and Trevo NXT products or kits. The expandable records identify documented events; affected models, lots and corrective actions must be checked in the FDA sources. These findings do not establish that every current model is recalled. [24][18][23][25][29][15][16][21][19][28][13][20][26][27][17][22][14]
Counts are documented minimums. Some recall mappings involve older configurations. ProCuity premarket status and the De Novo review remain unresolved. [72]
Latest recorded source review: 2026-10-28.
Scope: selected product families.
| Recalled product / record | Initiated | Source |
|---|---|---|
| September 16, 2026 | [29][63][64][65][66] |
| July 30, 2026 | [28][61][62] |
| April 13, 2026 | [27][60] |
| January 21, 2025 | [26][59] |
| September 4, 2024 | [25][58] |
| August 7, 2024 | [24][57] |
| April 23, 2024 | [22][50] |
| April 15, 2024 | [23][51][52][53][54][55][56] |
| February 6, 2024 | [21][42][43][44][45][46][47][48][49] |
| August 30, 2023 | [20][39][40][41] |
| April 13, 2023 | [19][37][38] |
| March 10, 2023 | [18][35][36] |
| June 3, 2022 | [17][34] |
| March 30, 2022 | [16][33] |
| November 24, 2021 | [15][32] |
Selected product families from the company’s commercial portfolio.
Robotic-arm assisted platform combining CT-based planning and haptic guidance for total knee, total hip and partial knee replacement. This snapshot covers joint-replacement applications; spine and shoulder applications are outside its selected scope. [77][4]
Marketed · selected total knee application has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Knee replacement implant family spanning primary and related reconstruction options. Cemented and cementless configurations are grouped within one family; individual components and surgical trays are not separate snapshots. [75][5]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Acetabular cup family used in hip replacement. Includes Tritanium porous titanium and hydroxyapatite-coated shell options, with instrumentation for manual or Mako-assisted procedures. [76][6]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Intramedullary nail and instrument system for tibial fracture fixation. Includes targeting instruments and locking screw options. This profile covers tibial applications. [83][7]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Battery-powered surgical tool platform with saws, drivers, batteries and charging equipment. The platform includes related attachments and cutting accessories. [80][11]
Marketed · FDA evidence covers the battery container onlyDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
4K surgical visualization platform with camera heads, a camera control unit and compatible lighting and imaging modes. Capabilities depend on the selected components, software, imaging agent and authorized use. [74][12]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Connected medical-surgical bed family with bed-exit monitoring and patient-support features. This profile covers LEX and ZX configurations. [72]
Marketed · premarket status not established in this reviewDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Professional monitor/defibrillator for hospital and emergency medical service settings. Combines cardiac monitoring and defibrillation in a portable platform; accessory and software configurations vary. [73][2]
Marketed · model documented by a PMA supplementDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Stent-retriever family for mechanical clot removal in acute ischemic stroke, subject to device labeling and patient-selection requirements. Retriever sizes and related delivery accessories are not listed individually. [79][10]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Implantable flow-diversion system for the endovascular treatment of specified intracranial aneurysms. Its braided implant redirects blood flow; eligibility and anatomy must be checked against the applicable labeling. [78][3]
Marketed · model documented by a PMA supplementDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Inari-origin mechanical thrombectomy platform for pulmonary embolism. The system combines aspiration catheters and clot-engagement components; individual catheter sizes and adjuncts remain grouped. [81][8]
Marketed · selected configuration has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Surgical planning and navigation platform with optical tracking and cranial or spine software applications. This is enabling technology, distinct from the U.S. spinal implants business sold to VB Spine. [82][9]
Marketed · selected cranial application has FDA clearanceDocumented on the manufacturer’s U.S. product site; configuration and local availability require confirmation.
Completed the sale of the U.S. spinal implants business. Navigation and enabling technology should not be conflated with the divested implant portfolio. [70]
Added a peripheral vascular business, including the FlowTriever and ClotTriever thrombectomy platforms. [1]
Accessed 10/28/2026